DEFA14A: SeaStar Medical Holding Corporation to Hold Annual Stockholders Meeting

SeaStar Medical Holding Corporation will hold its annual meeting of stockholders on July 3, 2025, to vote on key proposals including the election of directors, an amendment to the equity incentive plan, approval of potential stock sales to Lincoln Park Capital Fund, and ratification of the company's accounting firm.

Summary

• SeaStar Medical Holding Corporation is holding its Annual Meeting of Stockholders on July 3, 2025.
• The meeting will be held live via the internet.
• Stockholders of record as of May 5, 2025, are eligible to vote.
• The proposals include electing two Class III Directors, Eric Schlorff and Kenneth Van Heel, to serve until the 2028 annual meeting.
• Another proposal involves amending and restating the Company's 2022 Omnibus Equity Incentive Plan to increase the authorized shares of common stock from 570,457 to 2,070,457 and remove the evergreen provision.
• Stockholders will also vote on approving the potential future sale and issuance of shares to Lincoln Park Capital Fund, LLC, which could result in Lincoln Park owning over 19.99% of the company's common stock.
• The appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2025, will be ratified.
• Finally, stockholders will vote on adjourning or postponing the Annual Meeting if necessary to permit further solicitation of proxies.

Sentiment

Score: 6

Explanation: The document is neutral in tone, presenting standard corporate governance matters for shareholder approval. The potential equity dilution is a slight negative, balanced by routine director elections and auditor ratification.

Positives

• The proposed amendment to the equity incentive plan could provide more flexibility for employee compensation and retention.
• Ratifying the appointment of an independent accounting firm ensures financial oversight and transparency.

Negatives

• The potential sale of shares to Lincoln Park Capital Fund, LLC, resulting in their ownership exceeding 19.99%, could dilute existing shareholders' equity.

Risks

• The potential stock issuance to Lincoln Park Capital Fund, LLC could dilute existing shareholders.
• Failure to secure enough votes for any of the proposals could lead to uncertainty and require further solicitation efforts.

Future Outlook

The document outlines proposals for the future governance and financial structure of SeaStar Medical, including potential equity offerings and director elections.

Industry Context

This announcement is typical for publicly traded companies, outlining the agenda for the annual meeting where shareholders vote on key corporate governance matters.

Stakeholder Impact

• Shareholders will be impacted by the decisions made at the Annual Meeting, particularly regarding the equity incentive plan and potential stock sales.
• Employees may be affected by changes to the equity incentive plan.
• The company's financial stability and governance practices could influence its relationships with suppliers and creditors.

Next Steps

• Stockholders need to review the proxy materials and vote on the proposals.
• The company will hold the Annual Meeting on July 3, 2025, to finalize the votes and proceed with the approved actions.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Directors, Equity Incentive Plan, Lincoln Park Capital, Common Stock, WithumSmith+Brown, Voting, SeaStar Medical